Clinical trial Recruiting at 1 site Interventional Ages 6 to 9

Dia-Root Bio MTA vs MTA Plus forIndirect Pulp Capping in Young Permanent Molars

Official title: Clinical and Radiographic Evaluation of DIA-ROOT BIO MTA as an Indirect Pulp Capping Agent in Young Permanent Molars

Run by Tanta University · NCT07894523 · Data updated 2026-11-12

This trial tests whether Dia-Root Bio MTA works as an indirect pulp cap in kids’ first permanent molars better or similar to standard MTA Plus.

Quick facts

Study typeInterventional
Ages6 Years to 9 Years
SexAll
Enrollment20 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta)
StatusRecruiting
StartedNovember 2, 2025
Main results expectedNovember 2026
Study endsJanuary 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07894523 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy children aged 6 to 9 years with bilateral asymptomatic, restorable first permanent molars requiring indirect pulp capping.

Probably not a fit

Children with irreversible pulpitis, non-restorable molars, prior restorations on the target teeth, or periapical radiolucency may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a split-mouth design, children aged 6 to 9 with bilateral deeply carious first permanent molars receive indirect pulp caps with either Dia-Root Bio MTA or MTA Plus. Each child contributes one treated molar to each group, with glass ionomer base and composite restorations. Outcomes include clinical signs like pain, tenderness, and swelling, plus radiographic measures such as dentin bridge formation and radiodensity at 3, 6, and 9 months. Postoperative pain is recorded in the first 48 hours using a 4-point scale. The study is conducted at the dental faculty of Tanta University and aims to determine comparative effectiveness and safety of the two materials in pediatric patients.

Why it matters

Potential benefit: If Dia-Root Bio MTA proves at least as effective as MTA Plus, children may receive improved pulp protection with favorable radiographic healing.

How similar studies have gone: Previous studies in indirect pulp capping with mineral trioxide aggregates have reported favorable clinical and radiographic outcomes, supporting exploration of newer formulations like Dia-Root Bio MTA.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy cooperative children free from systemic diseases aged from 6 to 9 years.
* Asymptomatic restorable bilateral first permanent molars with deep carious occlusal lesions (ICDAS code 4, 5) with a positive response to vitality tests.
* Normal radiographic appearance (intact lamina dura, absence of internal and/or external root resorption, and no periapical radiolucency).

Exclusion Criteria:

* Signs and symptoms of irreversible pulpitis, such as spontaneous pain, pathological mobility, pain with percussion, fistula, or discoloration.
* Unrestorable molars
* Previously restored molars
* Periapical radiolucency or internal and/or external root resorption.

Where it's running

  • faculty of dentistry, Tanta university
    Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.